Showing results (1331-1340 of 5,275) with videos related to

Sort By:
Pageof 528
Oncology|July 10, 2010
Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in JapanMasatoshi Kudo, Kazuomi Ueshima
Oncology|August 25, 2010
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort studyMark F Kozloff, Jordan Berlin, Patrick J Flynn, et al.
Oncology|June 10, 2010
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancerFrancesco Boccardo, Dino Amadori, Pamela Guglielmini, et al.
Oncology|June 10, 2010
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantationMichael Brave, Ann Farrell, Sue Ching Lin, et al.
Oncology|August 28, 2010
Treatment of colorectal cancer with and without bevacizumab: a phase III studyG P Stathopoulos, C Batziou, D Trafalis, et al.
Oncology|January 23, 2009
Cytogenetic analysis of false-positive mucosa by photodynamic diagnosis using 5-aminolevulinic acid - possible existence of premalignant genomic alterations examined by in vitro experimentHideyasu Matsuyama, Yoshiaki Yamamoto, Kazuhiro Nagao, et al.
Oncology|January 23, 2009
Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patientsInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.
Oncology|February 12, 2009
The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian womenPavol Zubor, Andrea Stanclova, Karol Kajo, et al.
Oncology|February 12, 2009
The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancerMo-Jin Wang, Zong-Guang Zhou, Ling Wang, et al.
Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.
Pageof 528